Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update

Robert G MosesClinical Trials and Research Unit, South East Sydney and Illawarra Area Health Service, New South Wales, AustraliaAbstract: Type 2 diabetes is a progressive disease associated with high levels of morbidity and mortality and for which there is both a large and growing prevalence worldwi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Moses R
Format: article
Langue:EN
Publié: Dove Medical Press 2010
Sujets:
Accès en ligne:https://doaj.org/article/f258fc99a07a408ba0b23c9f089a972e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!